Mutaz M. Zogail

Mutaz M. Zogail


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
MAMohammed K. Alghamdi
Mohammed K. Alghamdi
RARena H. Alharbi
Rena H. Alharbi
YAYunus M. Al-Zahrani
Yunus M. Al-Zahrani
KHKhadija Habib
Khadija Habib
SSSamaa Sindi
Samaa Sindi
MZMutaz M. Zogail
Mutaz M. Zogail
Background/Objectives: Topical corticosteroids (TCS) are a cornerstone of dermatological treatment for inflammatory skin conditions; however, irrational fear of their use known as corticophobia undermines adherence and worsens clinical outcomes. This study investigated the prevalence of TCS-related concern and phobic behaviors among the general population in Saudi Arabia and identified factors associated with TCS-related concern and phobic attitudes. Methods: A cross-sectional study was conducted between October and December 2025 using an online self-administered questionnaire distributed via social media platforms among a non-probability convenience sample across multiple geographic zones of Saudi Arabia. A total of 481 participants were enrolled. Descriptive statistics summarized demographic and clinical characteristics. Chi-square and Fisher’s exact tests were used to examine differences in proportions between categorical variables and TCS concern, while independent-samples t-tests and one-way ANOVA compared mean phobia scores across subgroups. Results: Of 481 participants, 254 (52.8%, 95% CI 48.3–57.2) expressed concern about TCS use. The predominant reason for refusing prescribed TCS was fear of side effects (93.5%). Phobic behaviors included fear of long-term use (54.2%) and fear of application to sensitive skin areas (63.0%). On the Likert phobia-scale item, 237 (49.8%) totally agreed they would use TCS if prescribed; a separate dichotomous behavioral-intention item, administered only to non-current users (n = 308), showed that 201 (65.3%) would accept TCS if prescribed and 107 (34.7%) would refuse. Concern was significantly more prevalent among females (58.1%, BH-adj p = 0.005), married participants (61.7%, BH-adj p = 0.010), and those refusing prescribed TCS (77.6%, BH-adj p < 0.001). Mean phobia scores (theoretical range 7–28) were significantly higher among females (20.43 ± 4.06 vs. males 18.84 ± 4.68, p < 0.001), participants with Diploma-level education (21.64 ± 3.12, p < 0.001 across education strata), widowed/divorced individuals (21.82 ± 3.57, p = 0.008), and residents of the Southern (20.47 ± 3.99) and Northern (21.40 ± 3.34) regions (p = 0.002 across regions). Conclusions: TCS-related concern was expressed by over half the participants in this social media-recruited sample, posing a substantial barrier to effective dermatological care. Side-effect concern was the most frequently reported reason for refusing prescribed TCS. In adjusted analyses, female sex was the most consistent independent correlate of TCS-related concern and higher phobia score; married status was independently associated with greater concern. These associations should be replicated in probability-based samples before subgroup-targeted interventions are designed. Conclusions: TCS-related concern was prevalent (52.8%) among adults in Saudi Arabia and represented a substantial barrier to dermatological care. Female sex and married status were independently associated with greater concern. Clinicians should proactively address TCS misconceptions during dermatological consultations to improve treatment adherence.

22 September 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
SASaja A. Almraysi
Saja A. Almraysi
DODhiyaa Abdullah Hakem Otayf
Dhiyaa Abdullah Hakem Otayf
MJMohammad Abdu Jareebi
Mohammad Abdu Jareebi
AAAbdulaziz Ali Alagsam
Abdulaziz Ali Alagsam
GJGhazi I. Al Jowf
Ghazi I. Al Jowf
FAFarjah Hassan Alqahtani
Farjah Hassan Alqahtani
Background/Objectives: Red eye is a common ocular complaint, yet population data from Saudi Arabia are limited and largely confined to specific diagnostic entities. This study assessed the proportion of adults reporting red eye and described its clinical characteristics, perceived triggers, management practices, and associated factors. Methods: A cross-sectional survey was conducted between November 2025 and March 2026 among adults aged 18 years or older in Saudi Arabia, recruited by convenience sampling through social media. A structured self-administered questionnaire captured sociodemographic, systemic, ocular, and lifestyle characteristics and, among affected participants, symptom profile, triggers, and management. The outcome was ascertained with a single screening item, accompanied by a photograph to aid recognition, asking whether participants currently had, or had previously had, red eye. Multivariable logistic regression identified independently associated factors (p < 0.05). Results: Of 1670 responses, 1627 were analysed after exclusion of duplicates and implausible anthropometric entries. Current or previous red eye was reported by 474 participants (29.1%; 95% CI: 26.9–31.4). Most reported no or only slight effect on daily life (85.4%), and 76.8% of episodes resolved within 48 h. Independently associated factors were male sex (aOR = 1.76; 95% CI: 1.23–2.52; p = 0.002), cosmetic use around the eyes (aOR = 1.74; 95% CI: 1.20–2.53; p = 0.003), allergic rhinitis or sinusitis (aOR = 1.86; 95% CI: 1.38–2.52; p < 0.001), hypertension (aOR = 1.74; 95% CI: 1.04–2.91; p = 0.035), chronic anxiety disorder (aOR = 1.67; 95% CI: 1.09–2.55; p = 0.018), and higher education. Physical activity showed a graded inverse association (aOR = 0.57; 95% CI: 0.41–0.81 for the highest category). Only 27.6% consulted a physician, and 13.3% used whitening eye drops. Conclusions: Red eye was commonly recognised but usually infrequent, brief, and minimally disabling. As the outcome was a single unvalidated self-report item not bounded in time, these findings describe reported symptom burden rather than confirmed disease.